Does Keppra Cause Mood Changes?
Yes, Keppra (levetiracetam) can cause mood changes, including irritability, aggression, anxiety, depression, and emotional lability. These are recognized side effects listed in the drug's FDA-approved labeling and clinical data. In premarketing studies, behavioral symptoms occurred in up to 13% of pediatric patients (versus 6% placebo) and 6% of adults (versus 4% placebo), with irritability most common.[1][2]
How Common Are Mood Changes with Keppra?
Mood-related adverse events affect 5-15% of users, varying by age and dose. Children and adolescents report higher rates—irritability in 11-13%, aggression in 7-9%. Adults see lower incidence: mood swings or hostility in 1-6%. Symptoms often start within the first month and may resolve with dose adjustment or discontinuation.[1][3]
Why Does Keppra Affect Mood?
The exact mechanism is unclear, but levetiracetam binds synaptic vesicle protein 2A (SV2A), potentially disrupting neurotransmitter balance without strongly affecting GABA or glutamate receptors like other antiepileptics. This may indirectly heighten emotional reactivity, especially in those with epilepsy-related brain changes.[2][4]
What Do Patients Report About Keppra Mood Swings?
User reviews on platforms like Drugs.com note "Keppra rage"—sudden anger or mood instability—in 10-20% of reports, often described as uncharacteristic outbursts. Some parents of pediatric patients switch drugs due to behavioral worsening; adults report anxiety or depression lifting after stopping.[5] Not all experience this; many tolerate it well.
How Does Keppra Compare to Other Epilepsy Drugs for Mood Effects?
Keppra has higher mood disruption rates than lamotrigine (mood stabilizer, <5% irritability) or topiramate (cognitive side effects but less rage). Carbamazepine or valproate show similar behavioral risks but more sedation. Guidelines recommend monitoring mood closely with Keppra, especially in youth.[3][6]
What Should You Do If Mood Changes Occur?
Consult a doctor immediately—do not stop abruptly, as seizures may worsen. Options include dose reduction (e.g., from 3000mg to 2000mg daily), switching to alternatives like lamotrigine, or adding antidepressants. Behavioral therapy helps some. FDA warns of rare suicidal ideation (0.5% risk across antiepileptics).[1][2]
Are There Risk Factors for Keppra-Induced Mood Issues?
Higher risk in children under 16, prior psychiatric history, high doses (>3000mg/day), or rapid titration. Genetic factors like SV2A variants may play a role, per emerging studies. No routine screening exists.[4][6]
[1]: FDA Label for Keppra
[2]: Keppra Prescribing Information
[3]: Glauser et al., New England Journal of Medicine (2007) – Pediatric trial data
[4]: Lynch et al., CNS Drugs (2004) – Mechanism review
[5]: Drugs.com Keppra Reviews
[6]: NICE Guidelines on Epilepsy (2022) – Behavioral monitoring